NeoGenomics, Inc. (NEO)
7.995
+0.24
(+3.16%)
USD |
NASDAQ |
Apr 02, 16:00
8.00
0.00 (0.00%)
Pre-Market: 20:00
NeoGenomics EPS Diluted (Quarterly) : -0.0768 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| Amphastar Pharmaceuticals, Inc. | 0.518 |
| Krystal Biotech, Inc. | 1.699 |
| Alignment Healthcare, Inc. | -0.0548 |
| Monte Rosa Therapeutics, Inc. | -0.7039 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.881M |
| Revenue (Quarterly) | 190.17M |
| Total Expenses (Quarterly) | 200.05M |
| Enterprise Value | 1.288B |
| Gross Profit Margin (Quarterly) | 39.81% |
| Profit Margin (Quarterly) | -5.20% |
| Earnings Yield | -10.56% |
| Normalized Earnings Yield | -7.971 |